Investigational Site Number :0360001

West Perth, Western Australia 6005

0 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Completed